PHARMADAN A/S Financials, key figures and credit report
Gross profit -6 382.7 kDKK FY 2024 -3.1% vs 2023
EBIT -6 468.7 kDKK FY 2024 -6.5% vs 2023
Net debt 21 053.8 kDKK FY 2024 +4.7% vs 2023
Quick ratio 0.1 FY 2024 -0.1 vs 2023
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -2 844.19 | -3 128.26 | -4 923.09 | -6 190.41 | -6 382.65 |
| Employee benefit expenses | - 349.90 | ||||
| Total depreciation | - 314.05 | - 311.71 | - 291.53 | - 233.41 | -86.08 |
| EBIT | -3 158.24 | -3 439.98 | -5 214.62 | -6 073.93 | -6 468.74 |
| Other financial income | 20.50 | 2.06 | |||
| Other financial expenses | -61.31 | - 109.84 | - 190.24 | - 481.98 | - 662.44 |
| Pre-tax profit | -3 219.55 | -3 529.32 | -5 404.86 | -6 555.91 | -7 129.11 |
| Income taxes | 708.30 | 776.45 | 1 237.18 | 1 442.30 | 1 702.47 |
| Net earnings | -2 511.25 | -2 752.87 | -4 167.68 | -5 113.61 | -5 426.64 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 989.72 | 785.03 | 493.50 | 262.55 | 176.47 |
| Tangible assets total | 989.72 | 785.03 | 493.50 | 262.55 | 176.47 |
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 955.91 | 800.00 | 1 655.47 | 2 201.67 | |
| Inventories total | 955.91 | 800.00 | 1 655.47 | 2 201.67 | |
| Current trade debtors | 253.85 | 179.91 | 400.38 | 938.65 | 0.60 |
| Prepayments and accrued income | 38.60 | 57.89 | 53.24 | ||
| Current deferred tax assets | 790.27 | 917.43 | 1 910.04 | 3 352.34 | 2 039.75 |
| Short term receivables total | 1 082.72 | 1 097.34 | 2 368.31 | 4 344.22 | 2 040.34 |
| Cash and bank deposits | 84.94 | 0.51 | 0.41 | 13.39 | 0.41 |
| Cash and cash equivalents | 84.94 | 0.51 | 0.41 | 13.39 | 0.41 |
| Balance sheet total (assets) | 3 113.29 | 2 682.87 | 4 517.69 | 6 821.83 | 2 217.22 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 600.00 | 600.00 | 600.00 | 600.00 | 600.00 |
| Retained earnings | 416.93 | -2 094.32 | -4 847.19 | -9 014.87 | -14 128.48 |
| Profit of the financial year | -2 511.25 | -2 752.87 | -4 167.68 | -5 113.61 | -5 426.64 |
| Shareholders equity total | -1 494.32 | -4 247.19 | -8 414.87 | -13 528.48 | -18 955.13 |
| Non-current liabilities total | |||||
| Current trade creditors | 262.33 | 208.72 | 256.07 | 221.26 | 110.31 |
| Current owed to group member | 4 332.32 | 6 692.27 | 12 668.67 | 20 117.91 | 21 054.21 |
| Other non-interest bearing current liabilities | 12.95 | 12.95 | 7.83 | 11.14 | 7.83 |
| Accruals and deferred income | 16.12 | ||||
| Current liabilities total | 4 607.61 | 6 930.06 | 12 932.56 | 20 350.31 | 21 172.35 |
| Balance sheet total (liabilities) | 3 113.29 | 2 682.87 | 4 517.69 | 6 821.83 | 2 217.22 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated